IR@PKUHSC  > 北京大学临床肿瘤学院  > 妇科肿瘤科
学科主题临床医学
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
Fu, Siqing2; Li, Yanfang1,4; Huang, Jie1; Liu, Tao1; Hong, Zhen1,5; Chen, Aiping1; Bast, Robert C.3; Kavanagh, John J.1; Gershenson, David M.1; Sood, Anil K.1,6,7; Hu, Wei1
关键词ovarian cancer Aurora kinases Aurora kinase inhibitors chemosensitization
刊名CANCER BIOLOGY & THERAPY
2012-09-01
DOI10.4161/cbt.21045
13期:11页:1034-1041
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
资助者Ovarian SPORE ; NIH ; Ovarian SPORE ; NIH
研究领域[WOS]Oncology
关键词[WOS]SUPPRESSES TUMOR-GROWTH ; HUMAN PANCREATIC-CANCER ; B-KINASE ; IN-VIVO ; SERINE/THREONINE KINASE ; CARCINOMA ; OVEREXPRESSION ; PACLITAXEL ; CISPLATIN ; VX-680
英文摘要

Aurora kinases are essential for regulation of chromosome segregation and cytokinesis during mitosis and play a role in growth and progression of human tumors, including ovarian cancer. Aurora A and Aurora B are frequently overexpressed in high-grade and low-grade ovarian cancers. Targeting Aurora kinases has great potential for improving the efficacy of chemotherapies of ovarian cancer. In this study, we investigated whether the Aurora kinase inhibitor, VE 465, can enhance the antitumor activity of carboplatin in human ovarian cancer cells. The antitumor activity of VE 465 was tested by MTT proliferative assay in multiple established human epithelial ovarian cancer cell lines of varying p53 status. VE 465 and carboplatin had a synergistic effect on cell viability in both platinum-sensitive and -resistant ovarian cancers. The growth-inhibitory effect was accompanied by reduction in expression of histone 3 and an increase in apoptosis. We conclude that VE 465 enhances the efficacy of carboplatin agents in ovarian carcinoma.

语种英语
所属项目编号P50 CA083639 (PP-DRP7) ; 5P30CA016672-32
资助者Ovarian SPORE ; NIH ; Ovarian SPORE ; NIH
WOS记录号WOS:000308694300008
Citation statistics
Cited Times:5[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66083
Collection北京大学临床肿瘤学院_妇科肿瘤科
作者单位1.Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
2.Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
3.Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
4.Sun Yat Sen Univ, Ctr Canc, Dept Gynecol Oncol, Guangzhou 510275, Guangdong, Peoples R China
5.Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
6.Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Mon Coding RNA, Houston, TX 77030 USA
7.Beijing Canc Hosp, Dept Gynecol, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Fu, Siqing,Li, Yanfang,Huang, Jie,et al. Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3[J]. CANCER BIOLOGY & THERAPY,2012,13(11):1034-1041.
APA Fu, Siqing.,Li, Yanfang.,Huang, Jie.,Liu, Tao.,Hong, Zhen.,...&Hu, Wei.(2012).Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.CANCER BIOLOGY & THERAPY,13(11),1034-1041.
MLA Fu, Siqing,et al."Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3".CANCER BIOLOGY & THERAPY 13.11(2012):1034-1041.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Fu, Siqing]'s Articles
[Li, Yanfang]'s Articles
[Huang, Jie]'s Articles
百度学术
百度学术Similar articles in
[Fu, Siqing]'s Articles
[Li, Yanfang]'s Articles
[Huang, Jie]'s Articles
必应学术
必应学术Similar articles in
[Fu, Siqing]'s Articles
[Li, Yanfang]'s Articles
[Huang, Jie]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.